Get the Stockscreener App
2.91
2.02%
-0.06
Atea Pharmaceuticals Inc stock is traded at $2.91, with a volume of 336.25K.
It is down -2.02% in the last 24 hours and down -16.86% over the past month.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
See More
Previous Close:
$2.97
Open:
$2.97
24h Volume:
336.25K
Relative Volume:
0.99
Market Cap:
$230.93M
Revenue:
$351.37M
Net Income/Loss:
$-174.01M
P/E Ratio:
-1.4058
EPS:
-2.07
Net Cash Flow:
$-126.94M
1W Performance:
-7.62%
1M Performance:
-16.86%
6M Performance:
-7.03%
1Y Performance:
-27.61%
1-Day Range:
$2.84
$3.00
1-Week Range:
$2.84
$3.327
52-Week Range:
$2.455
$4.095
Atea Pharmaceuticals Inc Stock (AVIR) Company Profile
Name
Atea Pharmaceuticals Inc
Sector
Industry
Phone
857-204-8109
Address
225 FRANKLIN STREET, BOSTON
Compare AVIR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AVIR
Atea Pharmaceuticals Inc
|
2.91 | 235.69M | 351.37M | -174.01M | -126.94M | -2.07 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.15 | 100.34B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
585.50 | 60.95B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
451.73 | 60.46B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
734.35 | 46.04B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
332.20 | 36.02B | 3.81B | -644.79M | -669.77M | -6.24 |
Atea Pharmaceuticals Inc Stock (AVIR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-13-24 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Aug-10-23 | Downgrade | JP Morgan | Neutral → Underweight |
| Jan-06-22 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Nov-18-21 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Oct-20-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Oct-05-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Nov-25-20 | Initiated | Evercore ISI | Outperform |
| Nov-24-20 | Initiated | JP Morgan | Overweight |
| Nov-24-20 | Initiated | Morgan Stanley | Overweight |
| Nov-24-20 | Initiated | William Blair | Outperform |
View All
Atea Pharmaceuticals Inc Stock (AVIR) Latest News
What machine learning models say about Atea Pharmaceuticals Inc.Weekly Trade Recap & Intraday High Probability Alerts - newser.com
Price action breakdown for Atea Pharmaceuticals Inc.IPO Watch & Weekly High Return Stock Opportunities - newser.com
How to use a screener to detect Atea Pharmaceuticals Inc. breakoutsEarnings Miss & AI Forecast Swing Trade Picks - newser.com
Sector ETF performance correlation with Atea Pharmaceuticals Inc.2025 Biggest Moves & Free High Accuracy Swing Entry Alerts - newser.com
US Stocks Recap: What dividend growth rate does Atea Pharmaceuticals Inc. offerWeekly Trend Summary & Fast Gain Swing Trade Alerts - خودرو بانک
Market reaction to Atea Pharmaceuticals Inc.’s recent news2025 Risk Factors & Weekly Setup with ROI Potential - newser.com
What high frequency data says about Atea Pharmaceuticals Inc.Quarterly Portfolio Report & Growth Focused Entry Reports - newser.com
heatmap analysis for atea pharmaceuticals inc. and competitorsWeekly Profit Report & Safe Capital Growth Stock Tips - newser.com
Detecting price anomalies in Atea Pharmaceuticals Inc. with AIDay Trade & Weekly Breakout Watchlists - newser.com
Earnings Risk: Is Atea Pharmaceuticals Inc still a buy after recent gainsMarket Performance Summary & Entry Point Strategy Guides - خودرو بانک
Acadian Asset Management LLC Lowers Holdings in Atea Pharmaceuticals, Inc. $AVIR - Defense World
What MACD and RSI say about Atea Pharmaceuticals Inc.Portfolio Performance Report & AI Forecasted Entry/Exit Points - newser.com
Momentum divergence signals in Atea Pharmaceuticals Inc. chart2025 Earnings Impact & Reliable Trade Execution Plans - newser.com
Can you recover from losses in Atea Pharmaceuticals Inc.Quarterly Performance Summary & Community Verified Watchlist Alerts - newser.com
What is the Moat Score of Atea Pharmaceuticals IncQuarterly Trade Review & Weekly Watchlist for Consistent Profits - خودرو بانک
Has Atea Pharmaceuticals Inc. found a price floor2025 Buyback Activity & Reliable Momentum Entry Alerts - newser.com
Will Atea Pharmaceuticals Inc. outperform the marketPortfolio Risk Summary & Verified Short-Term Trading Plans - newser.com
Is this a good reentry point in Atea Pharmaceuticals Inc.Market Activity Summary & Real-Time Volume Analysis Alerts - newser.com
Heatmap analysis for Atea Pharmaceuticals Inc. and competitorsJobs Report & Fast Entry Momentum Trade Alerts - newser.com
Will a bounce in Atea Pharmaceuticals Inc. offer an exitJuly 2025 Closing Moves & Advanced Swing Trade Entry Alerts - newser.com
Understanding Atea Pharmaceuticals Inc.’s price movementJuly 2025 Summary & Long-Term Growth Portfolio Plans - newser.com
Relative strength of Atea Pharmaceuticals Inc. in sector analysisJuly 2025 Closing Moves & Accurate Technical Buy Alerts - newser.com
Has Atea Pharmaceuticals Inc. formed a bullish divergence2025 Performance Recap & AI Powered Buy and Sell Recommendations - Newser
Price momentum metrics for Atea Pharmaceuticals Inc. explained2025 Price Action Summary & Low Drawdown Trading Strategies - Newser
Will Atea Pharmaceuticals Inc. continue its uptrend2025 Support & Resistance & Free Safe Capital Growth Stock Tips - Newser
Using AI based signals to follow Atea Pharmaceuticals Inc.July 2025 Sector Moves & Daily Volume Surge Signals - Newser
News impact scoring models applied to Atea Pharmaceuticals Inc.July 2025 Price Swings & Free Weekly Chart Analysis and Trade Guides - Newser
Is Atea Pharmaceuticals Inc. stock bottoming outJuly 2025 Momentum & Risk Managed Investment Entry Signals - Newser
Published on: 2025-09-12 16:19:18 - Newser
Applying Elliott Wave Theory to Atea Pharmaceuticals Inc.July 2025 Institutional & Intraday High Probability Alerts - Newser
Applying chart zones and confluence areas to Atea Pharmaceuticals Inc.2025 Year in Review & Reliable Entry Point Trade Alerts - Newser
Short interest data insights for Atea Pharmaceuticals Inc.Earnings Miss & Risk Managed Trade Strategies - Newser
Volatility clustering patterns for Atea Pharmaceuticals Inc.Trade Volume Report & Free Technical Confirmation Trade Alerts - Newser
Atea Pharmaceuticals Inc Stock (AVIR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.62%
0.57%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):